BRKR — Bruker Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapFalling Star

Annual income statement for Bruker, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,988	2,418	2,531	2,965	3,366
Cost of Revenue
Gross Profit	940	1,210	1,307	1,517	1,661
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,739	2,005	2,098	2,402	3,146
Operating Profit	248	413	433	563	221
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	226	394	414	544	207
Provision for Income Taxes
Net Income After Taxes	161	281	298	427	116
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	158	277	297	427	113
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	158	277	297	427	113
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	1.13	1.89	2.12	2.5	1.38
Dividends per Share